VolitionRx GC logs tax-share withholding move

VolitionRx Ltd reported an insider equity adjustment involving its General Counsel of Volition Diagnostics, Nicholas Plummer.

Rhea-AI Filing Summary

VolitionRx Ltd reported an insider equity adjustment involving its General Counsel of Volition Diagnostics, Nicholas Plummer. A total of 5,867 shares of common stock were retained by VolitionRx for cancellation to cover tax withholding on the settlement of 12,483 restricted stock units that had been awarded in lieu of cash compensation. The filing notes that no shares were sold by Plummer or by VolitionRx in this transaction. Following this tax-withholding disposition, Plummer directly holds 414,270 shares of VolitionRx common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 5,867 shares

Exercise Price or Tax Liability 1 txn

Insider Plummer Nicholas

Role GC - Volition Diagnostics

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	5,867	$0.213	$1K

Holdings After Transaction: Common Stock — 414,270 shares (Direct)

Footnotes (1)

1. F1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,483 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VolitionRx (VNRX) report for Nicholas Plummer?

VolitionRx reported a tax-withholding disposition for General Counsel Nicholas Plummer. The company retained 5,867 shares for cancellation to satisfy tax obligations related to the settlement of 12,483 restricted stock units granted in lieu of cash compensation.

Were any VolitionRx (VNRX) shares sold in the Nicholas Plummer Form 4 filing?

No shares were sold in this transaction. The filing explains that 5,867 shares were retained by VolitionRx for cancellation only to satisfy tax withholding obligations; neither Plummer nor the company sold shares on the open market.

How many VolitionRx (VNRX) shares were canceled for taxes for Nicholas Plummer?

5,867 shares of common stock were canceled by VolitionRx to satisfy Nicholas Plummer’s tax withholding obligations. This action was tied to the settlement of 12,483 restricted stock units previously awarded instead of cash compensation.

What equity award triggered the VolitionRx (VNRX) tax-withholding transaction for Nicholas Plummer?

The transaction was triggered by 12,483 restricted stock units settling for Nicholas Plummer. These RSUs were originally granted in lieu of cash compensation, and part of the resulting shares was canceled to cover related tax obligations.

How many VolitionRx (VNRX) shares does Nicholas Plummer hold after this Form 4 event?

Nicholas Plummer directly holds 414,270 VolitionRx shares following the tax-withholding disposition. This figure reflects his remaining common stock position after 5,867 shares were retained by the company for cancellation to satisfy tax obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plummer Nicholas

(Last) (First) (Middle)

1489 WEST WARM SPRINGS ROAD

SUITE 110

(Street)

HENDERSON NV 89014

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VOLITIONRX LTD [ VNRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	GC - Volition Diagnostics

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/01/2026		F		5,867(1)	D	$0.213	414,270	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 12,483 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction.

Remarks:

	/s/ Nicholas Plummer	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.